Companies: 10,795·Total market cap: $144.5T
Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc.

AVAHNASDAQHealthcare● Active
$6.64
$-0.04(-0.60%)
Market Cap$1.4B
P/E Ratio
52W High$10.32
52W Low$3.73
Overview

Aveanna Healthcare Holdings Inc. (AVAH) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

avah · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 12 Wall Street analysts in the past 3 months

SellBuy

Buy

12 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
7
Hold
4
Sell
1
Strong Sell
0
Total: 12 · Buy rate: 58.3%

12-Month Price Target

High

$11.00

Consensus

$10.00

+50.7% upside

Low

$9.00

Median: $10 · Last Close: $6.63

The Aveanna Healthcare Holdings Inc. (AVAH) analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month AVAH price target is $10.00, representing +50.7% upside from the current price of $6.63.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $10 (50.7%)

Consensus Target

$10.00

50.7% upside

High Target

$11

65.8%

Low Target

$9

35.6%

Current Price

$6.63

as of today

Based on analyst price targets, the AVAH stock price prediction for the next 12 months ranges from $9 to $11. The consensus AVAH price forecast of $10.00 implies 50.7% upside from the current price of $6.63.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$6.344.38%

1-day model range: $6.31–$6.38. Peak: $6.38 (-4.38%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$6-6.2%
2028$6-9.4%
2029$6-11.1%
2030$6-12.0%
2031-12.5%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%0%93%
1Buy
0Neutral
13Sell
RSI (14)23.4Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · AVAH · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$6.64SELL
MA 10$6.90SELL
MA 20$7.12SELL
MA 50$6.79SELL
MA 100$7.23SELL
MA 200$7.99SELL
Current $AVAH · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$6.71SELL
EMA 10$6.85SELL
EMA 20$6.94SELL
EMA 50$6.98SELL
EMA 100$7.19SELL
EMA 200$7.19SELL
Current $AVAH · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
RBC Capital2026-06-03
Upgrade ↑
Sector PerformOutperform
Truist Securities2026-05-20
Maintains
HoldHold
Barclays2026-05-18
Maintains
OverweightOverweight
Stephens & Co.2026-05-15
Upgrade ↑
Equal WeightOverweight
RBC Capital2026-05-15
Maintains
Sector PerformSector Perform
Truist Securities2026-04-13
Maintains
HoldHold
Barclays2026-03-25
Maintains
OverweightOverweight
RBC Capital2026-03-23
Maintains
Sector PerformSector Perform
Truist Securities2026-03-20
Maintains
HoldHold
BMO Capital2026-03-20
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Aveanna Healthcare Holdings Inc. (AVAH) stock. Of the recent 70 rating actions, 7 were upgrades and 10 were downgrades. 12 analysts currently cover AVAH.

Analyst Recommendation Trends

Buy ratings01↑ +1
Hold ratings202
Sell ratings00

AVAH analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$2.0B

↓ 22.9% YoY

Revenue Next Year

$2.4B

↑ 20.3% YoY

EPS This Year

$0.01

EPS Next Year

$0.58

↑ 4822.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AVAH EPS of $0.01 for the current fiscal year, based on estimates from 6 analysts. The AVAH revenue forecast is $2.0B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The AVAH stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AVAH price target is $10.00 (+50.7% upside), with an analyst consensus of Buy.

The AVAH short-term stock prediction for tomorrow is $6.34 (-4.38%). The AVAH stock price prediction for 2027 estimates an average of $6. The AVAH stock prediction for 2030 projects a range of $5–$6.

Aveanna Healthcare Holdings Inc. trades on NASDAQ under the ticker AVAH. The AVAH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 58% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

AVAH forecast · 8 questions

According to 12 Wall Street analysts, the average 12-month AVAH price target is $10.00, with a high forecast of $11.00 and a low of $9.00. The median price target is shown in the chart above when available. This implies +50.7% potential upside from the current price of $6.63.

AVAH price targetWhat is AVAH price targetAVAH analyst price targetAVAH 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.